279
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Perceived harms of and exposure to tobacco use and current tobacco use among reproductive-aged women from the PATH study

, PhD, MPHORCID Icon, , PhD, MPH, , MS, , MHA & , PhD, MPH
Pages 1040-1051 | Received 05 Nov 2019, Accepted 19 Jun 2020, Published online: 12 Jul 2020
 

ABSTRACT

Data for this study were obtained from reproductive-aged women (aged 18–44 years, at wave 1) from waves 1 (2013–2014) and 2 (2014–2015) of the Population Assessment of Tobacco and Health Study (n = 13,241). Bivariate and multinomial regression analyses were performed associating past 30-day use of cigarettes only, e-cigarettes only, and dual use with perceptions of harm, exposure to tobacco product use, and sociodemographic variables. Cross-sectional and longitudinal analyses were conducted. Of all reproductive-aged women included in the analyses, 75.5 percent reported no tobacco use, 16.9 percent reported cigarette use only, 1.5 percent reported e-cigarette use only, and 6.1 percent reported dual use within the past 30 days. Perceived harm, tobacco exposure, pregnancy status, age, race/ethnicity, income, education, and sexual orientation were associated with the past 30-day use, cross-sectionally at wave 1. Similar associations were found for longitudinal analyses using wave 2 data, except for income and education, which were no longer associated. The results of this study contribute to knowledge regarding the prevalence and correlates of tobacco use across exclusive cigarette, exclusive e-cigarette, and dual use among reproductive-aged women.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

The Population Assessment of Tobacco and Health Study is supported with federal funds from the National Institute on Drug Abuse, National Institutes of Health, and the Food and Drug Administration, Department of Health and Human Services under a contract with Westat [HHSN271201100027C]. The views and opinions expressed in this manuscript are those of the authors only and do not necessarily represent the views, official policy, or position of the U.S. Department of Health and Human Services or any of its affiliated institutions or agencies. Additional support is provided by the National Cancer Institute of the National Institutes of Health [T32CA093423] to NEN.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.